Search
Sinovac Pharmaceutical Forms Strategic Alliance with Tianyu Pharmaceutical Subsidiary Nord Pharmaceutical
2025-05-01 /
Read about 0 minute
Author：小编
Sinovac Pharmaceutical and Nord Pharmaceutical, a member of the Tianyu Pharmaceutical Group, have entered into a strategic partnership, centering on the exclusive overseas commercialization of Sitagliptin Phosphate Tablets in key markets such as Saudi Arabia and Algeria. This collaboration endeavors to propel Sinovac Pharmaceutical and Nord Pharmaceutical towards jointly tapping into the global diabetes medication market. By harnessing Sinovac Pharmaceutical's extensive experience in overseas commercialization and Nord Pharmaceutical's strengths in drug manufacturing, the partnership aims to enhance the accessibility of Sitagliptin Phosphate Tablets in emerging markets worldwide.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
